# Unite.AI — Isomorphic Labs Raises $5B Series C to Advance AI Drug Design

- Company: Unite.AI (unite.ai)
- Announced: 2026-11-17T12:53:15+00:00
- Category: not stated
- Coverage: not counted
- Announcement: yes
- Group: announcements
- Source: https://www.unite.ai/isomorphic-labs-raises-5b-series-c-to-advance-ai-drug-design/
- Record: https://forck.live/items/37227-isomorphic-labs-raises-5b-series-c-to-advance-ai-drug-design
- Subject: Reporting

Isomorphic Labs raised $5 billion in Series C funding to expand its AI drug-design engine and clinical infrastructure. The company's IsoDDE engine designs drug-like molecules while proprietary agents reason through complex biology. Isomorphic's central test is whether reported preclinical progress translates into clinical evidence in human trials. Isomorphic Labs announced on November 17, 2026 that it had raised $5 billion in Series C funding co-led by Greenoaks and Sequoia Capital, giving the AI drug-discovery company new capital to expand its design engine and move therapeutic candidates toward clinical trials. The oversubscribed round includes Andreessen Horowitz and several other new investors, alongside another significant investment from Alphabet. Every existing investor returned: Thrive Capital, MGX, GV, CapitalG, Temasek and the UK Sovereign AI Fund. Proceeds will fund further development of IsoDDE, the company’s proprietary drug-design engine, expansion into new areas of biology, and global infrastructure for AI-led bioengineering. Isomorphic is also creating a partner ecosystem to study the mechanisms that drive disease. …

---

Record: https://forck.live/items/37227-isomorphic-labs-raises-5b-series-c-to-advance-ai-drug-design
Catalogue: https://forck.live/llms.txt
Current issue: https://forck.live/feed.md
